Serum creatine phosphokinase (CPK) levels, particularly the CPK-MB isoenzyme, are clinically utilized to diagnose acute myocardial infarction, with elevated ratios of CK-MB2 to CK-MB1 isoforms indicating myocardial necrosis within hours of infarction onset.